Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers

Journal of the American College of Cardiology

Volumn 28, Issue 5, 1996, Pages 1161-1167

  Kugiyama, Kiyotaka ^a   Yasue, Hirofumi ^a   Ohgushi, Masamichi ^a   Motoyama, Takeshi ^a   Kawano, Hiroaki ^a   Inobe, Yoshito ^a   Hirashima, Osamu ^a   Sugiyama, Seigo ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY TONE; ARTICLE; BLOOD VESSEL DIAMETER; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ACETYLCHOLINE; AGED; ARTERIES; CORONARY CIRCULATION; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITROGLYCERIN; OMEGA-N-METHYLARGININE; PERICARDIUM; SMOKING; VASODILATION;

EID: 0030297755     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00325-7     Document Type: Article

References (51)

1. 1. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomoter response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
2. 2. Zeiher AM, Drexler H, Saurbrier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
3. 3. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment; possible role of early coronary atherosclerosis. Circulation 1990;81:482-90.
4. 4. Ouyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest 1995;95:1747-55.
5. 5. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA 1988;259: 1025-9.
6. 6. Wilson PWF, Christiansen JC, Anderson KM, Kannel WB. Impact of national guidelines for cholesterol risk factor screening: the Framingham Offspring Study. JAMA 1989;262:41-4.
7. 7. Jonas MA, Gates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for health care professionals. Circulation 1992; 86:1664-9.
8. 8. Konishi M, Iida M, Naito Y, et al. The trend of coronary heart disease and its risk factors based on epidemiological investigations. Jpn Circ J 1987;51: 319-24.
9. 9. Dawber TR. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge (MA): Harvard University Press, 1980:172-89.
10. 10. Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J, the Cardiovascular Health Study (CHS) Collaborative Research Group. Relation of smoking with carotid artery wall thickness and stenosis in older adults: the Cardiovascular Health Study. Circulation 1994;90:2905-8.
11. 11. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 1994;266:H874-80.
12. 12. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-100.
13. 13. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
14. 14. Nishida K, Harrison DG, Navas JP, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992;90:2092-6.
15. 15. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992;89:6348-52.
16. 16. Chu A, Chambers DE, Lin C, et al. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 1991;87:1964-8.
17. 17. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2:997-1000.
18. 18. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation 1993;88:43-54.
19. 19. Moncada S, Rees DD, Schulz R, Palmer RMJ. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 1991;88:2166-70.
20. 20. Fuchgott RF. Role of endothelium in response of vascular smooth muscle. Circ Res 1983;53:557-73.
21. 21. Ignarro LJ. Biological action and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989;65:1-21.
22. 22. Vanhoutte PM. The endothelium. Modulator of vascular smooth muscle tone. N Engl J Med 1988;319:512-3.
23. 23. Bassenge E. Coronary vasomotor responses: role of endothelium and nitrovasodilators. Cardiovasc Drugs Ther 1994;8:600-12.
24. 24. Yasue H, Horio Y, Kugiyama K, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-63.
25. 1 receptor stimulation on coronary artery diameter in patients with variant angina: comparison with effect of acetylcholine. J Am Coll Cardiol 1991;17:338-45.
26. 26. Bossaller C, Habib GB, Yamamoto H. Williams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987;79:170-4.
27. 27. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. the case for a distinction. Circulation 1990;81:1983-91.
28. 28. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III. Contribution of nitric oxide to metabolic coronary vasoditation in the human heart. Circulation 1995;92:320-6.
29. 29. Shimao T. Smoking and its control in Japan. Asian Med J 1988;31:195-200.
30. 30. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986;124:903-15.
31. 31. Shimamoto T, Komachi Y, Inada H, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989;79:503-15.
32. 32. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9.
33. 33. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation 1992;85:905-9.
34. 34. Hoffman D, Hecht SS, Ornaf RM, Wynder EL, Tso TC. Chemical studies on tobacco smoke. XLII. Nitrosonornicotine: presence in tobacco, formation and carcinogenicity. IARC Sci Publ 1976;14:307-20.
35. 35. Bokhoven C, Niessen HJ. Amounts of oxides of nitrogen and carbon monoxide in cigarette smoke, with and without inhalation. Nature 1961;192: 458-9.
36. 36. Nakayama T, Kodama M. Generation of hydrogen peroxide and superoxide anion radical from cigarette smoke. Gann 1984;75:95-8.
37. 37. Gruetter CA, Barry BK, Mcnamara DB, Kadowitz PJ, Ignarro LJ. Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N′-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther 1980;214:9-15.
38. 38. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986;73:662-7.
39. 39. Nichols AB, Gabrieli CFO, Fenoglio JJ, Esser PD. Quantification of relative coronary arterial stenosis by videodensitometric analysis of the coronary angiograms. Circulation 1984;69:512-22.
40. 40. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88(Pt 1):2149-55.
41. 41. Schächinger V, Zeiher AM. Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomoter tone in atherosclerosis. Circulation 195;92:2087-94.
42. 42. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
43. 43. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima fromation and impairs endothelial function in hyperchlesterolemic rabbits. Arteriosclerosis Thrombosis 1994; 14:753-9.
44. 44. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987;317:1303-9.
45. 45. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project. J Chronic Dis 1978;31:201-306.
46. 46. Asmussen G, Kjeldsen K. Intimal ultrastructure of human umbilical arteries: observations on arteries from newborn children of smoking and nonsmoking mothers. Circ Res 1975;36:579-89.
47. 47. Reinders JH, Brinkman HJ, van Mourik JA, de Groot PG. Cigarette smoke impairs endothelial cell prostacyclin production. Arteriosclerosis 1986;6:15-23.
48. 48. Murohara T, Kugiyama K, Sugiyama S, Ohgushi M, Yasue H. Activated human polymorphonuclear leukocytes elicit endothelium-dependent contraction in isolated pig coronary arteries. J Cardiovasc Pharmacol. 1993;21: 760-6.
49. 49. White CR, Brock TA, Chang LY, et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 1994;91:1044-8.
50. 50. Duthie GG, Wahle KWJ, James WPT. Oxidants, antioxidants and cardiovascular disease. Nutr Res Rev 1989;2:51-62.
51. 51. Duthie GG, Wahle KWJ. Smoking, antioxidants essential fatty acids and coronary heart disease. Biochem Soc Trans 1990;18:1051-4.